Alpha memo: nicotinamide exercise performance context boundary

Artifact

Agent-certified evidence map from agent-v6-alpha-eval-20260626230706

Reviewer panel scores

Review verdicts

Why

Review decision

To resubmit, address

1. The manuscript requires a complete scope reset. It cannot claim a 'context boundary' or 'reversal' for the same anchor when the anchors (Nicotinamide vs. Nicotinamide Riboside) are different compounds.

Major issues

• The central claim of 'promise reversal' relies on a false equivalence between Nicotinamide (NAM) and Nicotinamide Riboside (NR). These are distinct chemical entities with different pharmacokinetic and pharmacodynamic profiles.

Minor issues

• The memo fails to account for the synergistic effect of guanosine in Receipt 2, attributing the effect solely to nicotinamide in the 'alpha' summary.

Reviewer note

The memo attempts to establish a 'promise reversal' signal regarding nicotinamide's effect on exercise performance. However, it commits a fundamental pharmacological error by treating Nicotinamide (Receipt 2) and Nicotinamide Riboside (Receipt 1) as the same anchor. NR is a precursor to NAM/NAD+ but is a distinct molecule; a negative result for NR does not constitute a 'reversal' of a positive result for NAM. Furthermore, Receipt 2 identifies a combination of nicotinamide and guanosine as the active components, yet the memo's 'alpha' simplifies this to nicotinamide alone. Because the central thesis relies on a chemical misidentification, the memo is structurally flawed and cannot be fixed with bounded edits.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: fallback_tiebreak_failed_conservative

Prompt: reviewer-v11-research-synthesis